Delivery Order SPE2DB22D3016-SPE2DB25FADG4

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,371.00 firm fixed price delivery order contract is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order valued at $3,812.90 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of the medical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" with a period of performance through March 2025. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $13,436.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, and has a firm fixed price pricing type with a completion date of March 21, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $1,949.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" with a completion date of March 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,525.20, is a Delivery Order for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of December 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,731.23 firm fixed-price delivery order contract is for ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,707.20 firm fixed-price delivery order is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,590.72 firm fixed price delivery order is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $2,108.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML", a medical product, with a completion date of November 27, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,613.76 delivery order contract is for the supply of "ZEPBOUND 10 MG/0.5 ML PEN 0.5ML" medical products. The contract has a firm fixed price pricing type and an ultimate completion date of February 28, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FADG4
    Delivery Order

This federal contract award, valued at $3,599.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, covers the supply of a specific medical product, ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of November 14, 2024. The contract does not have a set-aside designation, indicating it was awarded through open competition.

AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/20/25, 2:00 PM